Division of Pfizer Inc.
Latest From Pfizer Ltd.
Eisai Pharmaceuticals India's managing director has left the company and plans to start his own venture.
Pfizer’s Vizimpro has been endorsed by an expert panel in India, paving the way for its potential introduction on the market, where other EGFR inhibitors including AstraZeneca’s Tagrisso have a head start.
Basilea’s Cresemba appears on course to a debut in India and partner Pfizer expects the novel antifungal to bolster its existing portfolio in the segment. Pricing of the product will be keenly watched.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Pfizer Inc.
- Senior Management
Ken Moran, Chmn. & Managing Dir.
Ian Read, Pres.
- Contact Info
Phone: (44) 1301 616161
Sandwich, CT13 9NJ
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.